Related Experiment Video
Updated: Feb 2, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Bleeding and thrombotic events occur early in children on durable ventricular assist devices
Joanna Y Huang1, Vera Ignjatovic2, Bennett J Sheridan3
1Monash University, School of Clinical Sciences, Clayton, Victoria, Australia; Murdoch Children's Research Institute, Hematology Research Group, Parkville, Victoria, Australia; Royal Children's Hospital, Department of Clinical Hematology, Parkville, Victoria, Australia.
Insights
Bleeding and thromboembolism (TE) are major risks for children with durable ventricular assist devices (VADs). Most events occurred during heparin use or transition to warfarin, suggesting a need for anticoagulation strategy adjustments.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Durable ventricular assist devices (VADs) are crucial for managing pediatric end-stage heart failure.
- Bleeding and thromboembolism (TE) are significant complications in pediatric VAD recipients.
Purpose of the Study:
- To investigate the timing, incidence, and risk factors for bleeding and TE in children with VADs.
Main Methods:
- Retrospective cohort study of 44 children implanted with HeartWare HVAD or Berlin Heart EXCOR VADs over 8 years.
- Analysis of bleeding and TE events, including their timing and association with anticoagulation and antiplatelet therapies.
Main Results:
- Major bleeding occurred in 39% and TE in 16% (stroke) or 9% (arterial).
- Most bleeding (66%) and TE (40.5%) events happened during unfractionated heparin therapy.
- A significant proportion of bleeding (22%) and TE (38%) events occurred during the transition from heparin to warfarin.
Conclusions:
- Bleeding and TE complications in pediatric VAD patients are frequently linked to unfractionated heparin use or the heparin-to-warfarin transition period.
- Future research should focus on optimizing anticoagulation and monitoring strategies in the early post-operative phase for pediatric VAD recipients.
Introduction:
Durable Ventricular Assist Devices (VADs) are increasingly used in children with end-stage heart failure. Major complications are bleeding and thromboembolism (TE). Our objective was to determine the timing, incidence and risk factors for bleeding and TE in children implanted with VADs.
Methods:
This was a retrospective cohort of 8 years experience for children implanted with HeartWare HVAD and Berlin Heart EXCOR VADs at the Royal Children's Hospital, Melbourne.
Results:
44 patients were implanted with Berlin Heart EXCOR or HeartWare HVAD devices. Major bleeding occurred in 17 patients (39%), 7 (16%) experienced thromboembolic strokes, 13 (30%) required device exchange for TE, and 4 (9%) experienced arterial thromboembolism. Twenty-seven patients (61%) were transplanted, three (7%) recovered, and six (14%) remain on device when censored. Eight patients (18%) died on VAD, with leading causes being thromboembolic stroke and intracranial bleeding. The majority of bleeding events and thromboembolic events occurred while patients were on unfractionated heparin (bleeding 66%, TE 40.5%) or transitioning between heparin and warfarin (bleeding 22%, TE 38%). Majority of patients were on more than one antiplatelet agent at the time of a major bleeding (87%) or thromboembolic (89%) event.
Conclusions:
The majority of bleeding and TE events occurring in children supported with durable VADs occur when they are on unfractionated heparin or transitioning to warfarin. Modifications to anticoagulation and monitoring in the early post-operative periods should be a research focus.
Related Concept Videos
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Brick Durability, Strength, and Appearance
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Errors occurring during blood pressure monitoring
Several factors...
Integration of Synaptic Events

